Literature DB >> 5917422

Persistence of mucosal abnormality in ulcerative colitis.

A P Dick, L P Holt, E R Dalton.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5917422      PMCID： PMC1552432          DOI： 10.1136/gut.7.4.355

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS.

Authors:  J H BARON; A M CONNELL; J E LENNARD-JONES
Journal:  Br Med J       Date:  1964-01-11

2.  Clinical experience with suction biopsy of the rectal mucosa.

Authors:  A L FLICK; K F VOEGTLIN; C E RUBIN
Journal:  Gastroenterology       Date:  1962-06       Impact factor: 22.682

3.  Ulcerative colitis. A follow-up investigation with mucosal biopsy studies.

Authors:  A P DICK; M J GRAYSON
Journal:  Br Med J       Date:  1961-01-21

4.  Biopsy studies in ulcerative colitis.

Authors:  S C TRUELOVE; W C RICHARDS
Journal:  Br Med J       Date:  1956-06-09

5.  The value of rectal biopsy in the diagnosis of ulcerative colitis.

Authors:  S G MATTS
Journal:  Q J Med       Date:  1961-10
  5 in total
  13 in total

1.  Responses to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and mucosal cell counts.

Authors:  B I Korelitz; S C Sommers
Journal:  Am J Dig Dis       Date:  1976-06

2.  Quantification of autofluorescence imaging can accurately and objectively assess the severity of ulcerative colitis.

Authors:  Kentaro Moriichi; Mikihiro Fujiya; Masami Ijiri; Kazuyuki Tanaka; Aki Sakatani; Tatsuya Dokoshi; Shugo Fujibayashi; Katsuyoshi Ando; Yoshiki Nomura; Nobuhiro Ueno; Shin Kashima; Takuma Gotoh; Junpei Sasajima; Yuhei Inaba; Takahiro Ito; Hiroki Tanabe; Yusuke Saitoh; Yutaka Kohgo
Journal:  Int J Colorectal Dis       Date:  2015-08-13       Impact factor: 2.571

3.  Inflammatory Bowel Disease Patients' Willingness to Accept Medication Risk to Avoid Future Disease Relapse.

Authors:  Meenakshi Bewtra; Angelyn O Fairchild; Erin Gilroy; David A Leiman; Caroline Kerner; F Reed Johnson; James D Lewis
Journal:  Am J Gastroenterol       Date:  2015-10-20       Impact factor: 10.864

4.  Ulcerative colitis with ankylosing spondylitis.

Authors:  M I Jayson; I A Bouchier
Journal:  Ann Rheum Dis       Date:  1968-05       Impact factor: 19.103

5.  Ulcerative colitis in patients with ankylosing spondylitis.

Authors:  M I Jayson; I A Bouchier
Journal:  Proc R Soc Med       Date:  1968-04

6.  The outcome of surgery for ulcerative colitis.

Authors:  D W Daly
Journal:  Ann R Coll Surg Engl       Date:  1968-01       Impact factor: 1.891

7.  Amino acid incorporation into proteins of human normal and ulcerative colitis colonic mucosa.

Authors:  M Brotman
Journal:  Gut       Date:  1968-10       Impact factor: 23.059

8.  Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.

Authors:  Burton I Korelitz; Keith Sultan; Megha Kothari; Leo Arapos; Judy Schneider; Georgia Panagopoulos
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

9.  Inflammatory bowel disease in ankylosing spondylitis.

Authors:  M I Jayson; P R Salmon; W J Harrison
Journal:  Gut       Date:  1970-06       Impact factor: 23.059

10.  Microscopic activity in ulcerative colitis: what does it mean?

Authors:  S A Riley; V Mani; M J Goodman; S Dutt; M E Herd
Journal:  Gut       Date:  1991-02       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.